antigens, neoplasm

Preferred Label : antigens, neoplasm;

MeSH definition : Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.;

MeSH synonym : neoplasm antigens;

CISMeF acronym : CA;

MeSH hyponym : tumor antigens; Antigens, Tumor; Tumor Antigen; Antigen, Tumor;

MeSH annotation : coord IM with required neopl coords with /immunol (IM); Manual 24.4.4.1 ;

Wikipedia link : https://en.wikipedia.org/wiki/Antigens, neoplasm;

Is substance : O;

Details

Origin ID

D000951;

UMLS CUI

C0003335;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Indexing information
- 2G3 antigen [MeSH Supplementary Concept]
- 2H6 antigen, human [MeSH Supplementary Concept]
- 323-A3 antigen, human [MeSH Supplementary Concept]
- 9-O-acetyl-GD3 ganglioside [MeSH Supplementary Concept]
- BCA 225 protein, human [MeSH Supplementary Concept]
- CA9 protein, human [MeSH Supplementary Concept]
- CL-5A antigen, human [MeSH Supplementary Concept]
- DEK protein, mouse [MeSH Supplementary Concept]
- EFL1 protein, human [MeSH Supplementary Concept]
- ETAA1 protein, human [MeSH Supplementary Concept]
- GPA33 protein, human [MeSH Supplementary Concept]
- Gpa33 protein, mouse [MeSH Supplementary Concept]
- HAUS8 protein, human [MeSH Supplementary Concept]
- HCC1 autoantigen [MeSH Supplementary Concept]
- HER2-neu-derived peptide (654-662) [MeSH Supplementary Concept]
- HER2-neu-derived peptide (780-786) [MeSH Supplementary Concept]
- KIR3DL2 protein, human [MeSH Supplementary Concept]
- LGALS8 protein, human [MeSH Supplementary Concept]
- LK26 antigen [MeSH Supplementary Concept]
- MAGEA4 protein, human [MeSH Supplementary Concept]
- MAGEA6 protein, human [MeSH Supplementary Concept]
- MAGEB1 protein, human [MeSH Supplementary Concept]
- MAGEC2 protein, human [MeSH Supplementary Concept]
- MAGEE1 protein, human [MeSH Supplementary Concept]
- MIA-15-5 [MeSH Supplementary Concept]
- MIA2 protein, human [MeSH Supplementary Concept]
- MPC-1 antigen [MeSH Supplementary Concept]
- MUC-1 protein, human (950-958) [MeSH Supplementary Concept]
- MUT 1 peptide [MeSH Supplementary Concept]
- MUT 2 peptide [MeSH Supplementary Concept]
- NGP-1 antigen, human [MeSH Supplementary Concept]
- NPSA protein, human [MeSH Supplementary Concept]
- OGA protein, human [MeSH Supplementary Concept]
- POTE ankyrin domain family, member H, human [MeSH Supplementary Concept]
- Pvr protein, rat [MeSH Supplementary Concept]
- SLCO6A1 protein, human [MeSH Supplementary Concept]
- SPN protein, human [MeSH Supplementary Concept]
- TM4SF5 protein, human [MeSH Supplementary Concept]
- TRA-1-60 antigen, human [MeSH Supplementary Concept]
- TSHZ1 protein, human [MeSH Supplementary Concept]
- Thomsen-Friedenreich antigen [MeSH Supplementary Concept]
- UK114 antigen [MeSH Supplementary Concept]
- antigen LEC-A [MeSH Supplementary Concept]
- astrocytin [MeSH Supplementary Concept]
- breast cancer-associated antigen 200, human [MeSH Supplementary Concept]
- cancer basic protein, human [MeSH Supplementary Concept]
- ceramide 3 [MeSH Supplementary Concept]
- clara cell antigen [MeSH Supplementary Concept]
- colon carcinoma monosialoganglioside antigen [MeSH Supplementary Concept]
- cytolipin R [MeSH Supplementary Concept]
- decapeptide 810 [MeSH Supplementary Concept]
- dek protein, human [MeSH Supplementary Concept]
- dopachrome isomerase [MeSH Supplementary Concept]
- fetal sulfoglycoprotein antigen, human [MeSH Supplementary Concept]
- fibroblast activation protein alpha [MeSH Supplementary Concept]
- fucosylgloboside [MeSH Supplementary Concept]
- gp240 glycoprotein, human [MeSH Supplementary Concept]
- human probombesin C-terminal peptide [MeSH Supplementary Concept]
- immature laminin receptor protein, mouse [MeSH Supplementary Concept]
- integrin alphaEbeta7 [MeSH Supplementary Concept]
- interspecific embryonic antigen-2 [MeSH Supplementary Concept]
- invariant chain [MeSH Supplementary Concept]
- lung cancer-associated protein, LCAP [MeSH Supplementary Concept]
- malignin [MeSH Supplementary Concept]
- methionine sulfoxide reductase [MeSH Supplementary Concept]
- novikoff hepatoma antigenic proteins [MeSH Supplementary Concept]
- peptide p(1-24) [MeSH Supplementary Concept]
- proliferating cell nuclear antigen p145 [MeSH Supplementary Concept]
- protein p80 [MeSH Supplementary Concept]
- proto-oncogene proteins c-fgr [MeSH Supplementary Concept]
- recognins [MeSH Supplementary Concept]
- sarcoma-associated antigen S1 [MeSH Supplementary Concept]
- sialosylgloboside [MeSH Supplementary Concept]
- synovial sarcoma X breakpoint proteins [MeSH Supplementary Concept]
- thymus-leukemia antigens [MeSH Supplementary Concept]
- trophoblastic glycoprotein 5T4, human [MeSH Supplementary Concept]
- zinc glycinate [MeSH Supplementary Concept]
Metaterm(s)
- oncology [CISMeF Metaterm]
Record concept(s)
- antigens, neoplasm [MeSH concept]
- tumor antigens [MeSH concept]
Related MeSH Supplementary Concept(s)
- 22-1-1 antigen [MeSH Supplementary Concept]
- 4-O-acetyl-N-glycolylneuraminyl lactosylceramide [MeSH Supplementary Concept]
- 4B5 antigen [MeSH Supplementary Concept]
- A6H antigen [MeSH Supplementary Concept]
- AK-5 antigen [MeSH Supplementary Concept]
- ANKRD30A protein, human [MeSH Supplementary Concept]
- ARID4B protein, human [MeSH Supplementary Concept]
- B5 antigen [MeSH Supplementary Concept]
- BAGE protein, human [MeSH Supplementary Concept]
- BAGE2 protein, human [MeSH Supplementary Concept]
- BAGE3 protein, human [MeSH Supplementary Concept]
- BAGE4 protein, human [MeSH Supplementary Concept]
- BAGE5 protein, human [MeSH Supplementary Concept]
- BLCA-1 protein, human [MeSH Supplementary Concept]
- CA153 protein, human [MeSH Supplementary Concept]
- CA215 antigen, human [MeSH Supplementary Concept]
- CA9 protein, human [MeSH Supplementary Concept]
- CAB39L protein, human [MeSH Supplementary Concept]
- CAGE1 protein, human [MeSH Supplementary Concept]
- CASA antigen [MeSH Supplementary Concept]
- CCDC110 protein, human [MeSH Supplementary Concept]
- CCDC34 protein, human [MeSH Supplementary Concept]
- CD248 protein, human [MeSH Supplementary Concept]
- CD248 protein, mouse [MeSH Supplementary Concept]
- CD37 protein, human [MeSH Supplementary Concept]
- CDCP1 protein, human [MeSH Supplementary Concept]
- CDCP1 protein, mouse [MeSH Supplementary Concept]
- CDCP1 protein, rat [MeSH Supplementary Concept]
- CEACAM19 protein, human [MeSH Supplementary Concept]
- CLUAP1 protein, human [MeSH Supplementary Concept]
- CSAG1 protein, human [MeSH Supplementary Concept]
- CT45A1 protein, human [MeSH Supplementary Concept]
- CT47A11 protein, human [MeSH Supplementary Concept]
- CT7 antigen, human [MeSH Supplementary Concept]
- CT83 protein, human [MeSH Supplementary Concept]
- CTAG1B protein, human [MeSH Supplementary Concept]
- CTAG2 protein, human [MeSH Supplementary Concept]
- CTAGE5 protein, mouse [MeSH Supplementary Concept]
- Ccdc7b protein, mouse [MeSH Supplementary Concept]
- Cd37 protein, mouse [MeSH Supplementary Concept]
- Cd37 protein, rat [MeSH Supplementary Concept]
- Cep290 protein, human [MeSH Supplementary Concept]
- Cep290 protein, mouse [MeSH Supplementary Concept]
- DCAF12 protein, human [MeSH Supplementary Concept]
- DSCR8 lncRNA, human [MeSH Supplementary Concept]
- DSE protein, human [MeSH Supplementary Concept]
- DU-PAN-2 antigen, human [MeSH Supplementary Concept]
- EBAG9 protein, human [MeSH Supplementary Concept]
- EBAG9 protein, mouse [MeSH Supplementary Concept]
- EGP314 antigen [MeSH Supplementary Concept]
- ENTR1 protein, human [MeSH Supplementary Concept]
- EXOSC5 protein, human [MeSH Supplementary Concept]
- GAGE1 protein, human [MeSH Supplementary Concept]
- GAGE12B protein, human [MeSH Supplementary Concept]
- GAGE2A protein, human [MeSH Supplementary Concept]
- GAGE7 protein, human [MeSH Supplementary Concept]
- HAGE protein, mouse [MeSH Supplementary Concept]
- HBA-71 tumor antigen [MeSH Supplementary Concept]
- HCA66 protein, mouse [MeSH Supplementary Concept]
- HCC-22-5 antigen, human [MeSH Supplementary Concept]
- HMGN2P46 protein, human [MeSH Supplementary Concept]
- HMW-MAA [MeSH Supplementary Concept]
- HPR protein, human [MeSH Supplementary Concept]
- HepPar-1 protein, human [MeSH Supplementary Concept]
- KLHDC2 protein, human [MeSH Supplementary Concept]
- KU-BL-1 antigen, human [MeSH Supplementary Concept]
- KU-BL-2 antigen, human [MeSH Supplementary Concept]
- KU-MEL-1 antigen [MeSH Supplementary Concept]
- L3p40-50 antigen [MeSH Supplementary Concept]
- LGALS3BP protein, human [MeSH Supplementary Concept]
- LIPI protein, human [MeSH Supplementary Concept]
- LUZP4 protein, human [MeSH Supplementary Concept]
- LX-1 antigen [MeSH Supplementary Concept]
- MAGE-9 antigen, human [MeSH Supplementary Concept]
- MAGE-A10 antigen [MeSH Supplementary Concept]
- MAGE-E1 antigen, human [MeSH Supplementary Concept]
- MAGEA10 protein, human [MeSH Supplementary Concept]
- MAGEA11 protein, human [MeSH Supplementary Concept]
- MAGEA12 protein, human [MeSH Supplementary Concept]
- MAGEA3 protein, human [MeSH Supplementary Concept]
- MAGEA3 protein, mouse [MeSH Supplementary Concept]
- MAGEA4 protein, human [MeSH Supplementary Concept]
- MAGEA6 protein, human [MeSH Supplementary Concept]
- MAGEA6 protein, mouse [MeSH Supplementary Concept]
- MAGEA9 protein, human [MeSH Supplementary Concept]
- MAGEB1 protein, human [MeSH Supplementary Concept]
- MAGEB2 protein, human [MeSH Supplementary Concept]
- MAGEB4 protein, human [MeSH Supplementary Concept]
- MAGEC1 protein, human [MeSH Supplementary Concept]
- MAGEC2 protein, human [MeSH Supplementary Concept]
- MAGED1 protein, human [MeSH Supplementary Concept]
- MAGED2 protein, human [MeSH Supplementary Concept]
- MAGEF1 protein, human [MeSH Supplementary Concept]
- MART-2 protein, human [MeSH Supplementary Concept]
- MELOE-1 antigen, human [MeSH Supplementary Concept]
- MELOE-2 antigen, human [MeSH Supplementary Concept]
- MG7 antigen, human [MeSH Supplementary Concept]
- MGr1-antigen, human [MeSH Supplementary Concept]
- MIA2 protein, human [MeSH Supplementary Concept]
- MLAA-42 protein, human [MeSH Supplementary Concept]
- MMSA-1 antigen, human [MeSH Supplementary Concept]
- MOK protein, human [MeSH Supplementary Concept]
- Ma2 antigen [MeSH Supplementary Concept]
- Mage-X protein, human [MeSH Supplementary Concept]
- Mage-a2 antigen [MeSH Supplementary Concept]
- Mageb16 protein, mouse [MeSH Supplementary Concept]
- Mageb2 protein, mouse [MeSH Supplementary Concept]
- Mageb3 protein, mouse [MeSH Supplementary Concept]
- Maged2 protein, mouse [MeSH Supplementary Concept]
- Magel2 protein, mouse [MeSH Supplementary Concept]
- Melan-A 51-73 peptide [MeSH Supplementary Concept]
- NA88-A antigen [MeSH Supplementary Concept]
- NB-p260 antigen [MeSH Supplementary Concept]
- NCC-ST-421 antigen [MeSH Supplementary Concept]
- NEMF protein, human [MeSH Supplementary Concept]
- NUDCD1 protein, human [MeSH Supplementary Concept]
- NY-CO16 antigen, human [MeSH Supplementary Concept]
- NY-ESO-1 protein, human (91-110) [MeSH Supplementary Concept]
- NY-SAR-35 antigen, human [MeSH Supplementary Concept]
- Nova2 protein, mouse [MeSH Supplementary Concept]
- OGA protein, human [MeSH Supplementary Concept]
- P.polypeptide [MeSH Supplementary Concept]
- P7 antigen, human [MeSH Supplementary Concept]
- PAGE1 protein, human [MeSH Supplementary Concept]
- PAGE2 protein, human [MeSH Supplementary Concept]
- PAGE4 protein, human [MeSH Supplementary Concept]
- PAM4 protein, human [MeSH Supplementary Concept]
- PARIS-1 antigen [MeSH Supplementary Concept]
- PASD1 protein, human [MeSH Supplementary Concept]
- PCA-1 antigen, human [MeSH Supplementary Concept]
- PCC4 embryonic antigen [MeSH Supplementary Concept]
- PF-06263507 [MeSH Supplementary Concept]
- PHF20 protein, human [MeSH Supplementary Concept]
- PNL2 tumor biomarker [MeSH Supplementary Concept]
- PNMA5 protein, human [MeSH Supplementary Concept]
- POTE-2alpha protein, human [MeSH Supplementary Concept]
- POTE-2beta protein, human [MeSH Supplementary Concept]
- POTEE protein, human [MeSH Supplementary Concept]
- PPHLN1 protein, human [MeSH Supplementary Concept]
- PR92 antigen, human [MeSH Supplementary Concept]
- PRAME protein, human [MeSH Supplementary Concept]
- PSCA protein, human [MeSH Supplementary Concept]
- Pramel6 protein, mouse [MeSH Supplementary Concept]
- Pramel7 protein, mouse [MeSH Supplementary Concept]
- Psca protein, rat [MeSH Supplementary Concept]
- Q5 antigen, mouse [MeSH Supplementary Concept]
- RIOK1 protein, human [MeSH Supplementary Concept]
- RNF17 protein, human [MeSH Supplementary Concept]
- RON3 protein, Plasmodium falciparum [MeSH Supplementary Concept]
- RS-DJ-1 antigen [MeSH Supplementary Concept]
- SAGE1 protein, human [MeSH Supplementary Concept]
- SART1 protein, human [MeSH Supplementary Concept]
- SART3 protein, human [MeSH Supplementary Concept]
- SC142-reactive antigen, human [MeSH Supplementary Concept]
- SDCCAG3 protein, mouse [MeSH Supplementary Concept]
- SLC45A2 protein, human [MeSH Supplementary Concept]
- STEAP protein (262-270), human [MeSH Supplementary Concept]
- STEAP protein (86-94), human [MeSH Supplementary Concept]
- STEAP1 protein, human [MeSH Supplementary Concept]
- Sart1 protein, rat [MeSH Supplementary Concept]
- Steap2 protein, mouse [MeSH Supplementary Concept]
- T-lymphoma membrane glycoprotein 90, mouse [MeSH Supplementary Concept]
- TA90 immune complex [MeSH Supplementary Concept]
- TAA90K protein, human [MeSH Supplementary Concept]
- TACSTD2 protein, human [MeSH Supplementary Concept]
- TAG 12 [MeSH Supplementary Concept]
- TAK-B1 antigen [MeSH Supplementary Concept]
- TLP protein, rat [MeSH Supplementary Concept]
- TMEM52B protein, human [MeSH Supplementary Concept]
- TMEM54 protein, human [MeSH Supplementary Concept]
- TRAPPC1 protein, human [MeSH Supplementary Concept]
- TROP2 protein, mouse [MeSH Supplementary Concept]
- TSGF protein, human [MeSH Supplementary Concept]
- TURP-27 antigen, human [MeSH Supplementary Concept]
- TXNDC16 protein, human [MeSH Supplementary Concept]
- Taa1 protein, mouse [MeSH Supplementary Concept]
- UBC antigen [MeSH Supplementary Concept]
- UBXN11 protein, human [MeSH Supplementary Concept]
- UOEH-LC-1 antigen, human [MeSH Supplementary Concept]
- UTP6 protein, human [MeSH Supplementary Concept]
- VSIG1 protein, human [MeSH Supplementary Concept]
- WDR46 protein, human [MeSH Supplementary Concept]
- XAGE1A protein, human [MeSH Supplementary Concept]
- ZNFX1 protein, human [MeSH Supplementary Concept]
- adenocarcinoma antigen recognized by T cells-1 [MeSH Supplementary Concept]
- adenoma-associated antigen glycoprotein 87, human [MeSH Supplementary Concept]
- antigen BLA.36, human [MeSH Supplementary Concept]
- antigen CYFRA21.1 [MeSH Supplementary Concept]
- antigen G250 [MeSH Supplementary Concept]
- antigen LG2-C, human [MeSH Supplementary Concept]
- antigen p102 [MeSH Supplementary Concept]
- antigen p200 [MeSH Supplementary Concept]
- antigenic protein, guerin epithelioma, neoplasm [MeSH Supplementary Concept]
- beta1-meconial antigen [MeSH Supplementary Concept]
- bladder tumor-associated antigen [MeSH Supplementary Concept]
- blocking factor [MeSH Supplementary Concept]
- brain-associated small-cell lung cancer antigen [MeSH Supplementary Concept]
- breast cancer-associated antigen 200, human [MeSH Supplementary Concept]
- cancer testis antigen NXF2, human [MeSH Supplementary Concept]
- cancer-testis antigen P1A, mouse [MeSH Supplementary Concept]
- cancerocerebral antigen, human [MeSH Supplementary Concept]
- carcinoma-associated antigen 17-1A [MeSH Supplementary Concept]
- colon cancer-specific antigen 2, human [MeSH Supplementary Concept]
- colon-ovarian tumor antigen, human [MeSH Supplementary Concept]
- colon-specific antigen [MeSH Supplementary Concept]
- colorectal carcinoma-associated antigen, human [MeSH Supplementary Concept]
- colorectal tumor-associated antigen, human [MeSH Supplementary Concept]
- common chronic lymphatic leukemia antigen gp69, human [MeSH Supplementary Concept]
- cora antigen [MeSH Supplementary Concept]
- early prostate cancer antigen, human [MeSH Supplementary Concept]
- early prostate cancer antigen-2, human [MeSH Supplementary Concept]
- formalinized extracellular antigen [MeSH Supplementary Concept]
- gamma-fetal antigen [MeSH Supplementary Concept]
- gastro-intestinal mucus-associated antigens [MeSH Supplementary Concept]
- glycoprotein 40 antigen, human [MeSH Supplementary Concept]
- glycoprotein GP37 [MeSH Supplementary Concept]
- hairy cell leukemia antigen p35, human [MeSH Supplementary Concept]
- id tumor-specific protein, mouse [MeSH Supplementary Concept]
- integrin alphavbeta6 [MeSH Supplementary Concept]
- interspecific embryonic antigen-1 [MeSH Supplementary Concept]
- leukemoembryonic antigens [MeSH Supplementary Concept]
- male breast tumor associated antigen 72 kDa, human [MeSH Supplementary Concept]
- malignancy-associated nucleolar antigen, human [MeSH Supplementary Concept]
- mammary carcinoma antigen [MeSH Supplementary Concept]
- mammary serum antigen, human [MeSH Supplementary Concept]
- marek's disease tumor-associated surface antigen, avian [MeSH Supplementary Concept]
- melanoma-associated cell surface protein, 55-kDa, human [MeSH Supplementary Concept]
- melanoma-associated proteoglycan antigen, human [MeSH Supplementary Concept]
- meth A sarcoma-associated rejection antigen, mouse [MeSH Supplementary Concept]
- multiple myeloma special antigen-8, human [MeSH Supplementary Concept]
- myeloma-associated membrane antigen KMA [MeSH Supplementary Concept]
- oncofetal antigens [MeSH Supplementary Concept]
- organ-specific neoantigen [MeSH Supplementary Concept]
- osteosarcoma-associated antigen [MeSH Supplementary Concept]
- ovarian tumor associated antigen [MeSH Supplementary Concept]
- pRL1a protein, mouse [MeSH Supplementary Concept]
- pancreas-specific antigen [MeSH Supplementary Concept]
- pancreatic associated antigen, SPan-1 [MeSH Supplementary Concept]
- pancreatic cancer-associated antigen MUSE11 [MeSH Supplementary Concept]
- periphilin protein, mouse [MeSH Supplementary Concept]
- prostate cancer antigen 3, human [MeSH Supplementary Concept]
- psca protein, mouse [MeSH Supplementary Concept]
- sarcoma glycoprotein gp96 rejection antigens [MeSH Supplementary Concept]
- squamous cell carcinoma-related antigen [MeSH Supplementary Concept]
- steap protein, mouse [MeSH Supplementary Concept]
- tennessee antigen, human [MeSH Supplementary Concept]
- trifucosyl-Lewis-b antigen [MeSH Supplementary Concept]
- trophoblast antigen 2, rat [MeSH Supplementary Concept]
- tumor antigen TA-4, human [MeSH Supplementary Concept]
- tumor liberated protein, human [MeSH Supplementary Concept]
- tumor rejection antigen P815A, mouse [MeSH Supplementary Concept]
- tumor-associated (2,3)-sialyl-T antigen [MeSH Supplementary Concept]
- tumor-associated antigen 72 [MeSH Supplementary Concept]
- tumor-associated antigen, gp43 [MeSH Supplementary Concept]
- tumor-associated fetal antigen, rat [MeSH Supplementary Concept]
- tumor-associated transplantation antigen [MeSH Supplementary Concept]
See also
- neoplasm proteins [MeSH Descriptor]
- neoplasms [MeSH Descriptor]
Semantic type(s)
- Immunologic Factor [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients